| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Grown Rogue International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.89 |
| 52 Week High | CA$1.15 |
| 52 Week Low | CA$0.33 |
| Beta | 0.081 |
| 11 Month Change | -7.29% |
| 3 Month Change | -1.11% |
| 1 Year Change | 128.21% |
| 33 Year Change | 513.79% |
| 5 Year Change | 888.89% |
| Change since IPO | 206.90% |
Recent News & Updates
Investors Interested In Grown Rogue International Inc.'s (CSE:GRIN) Revenues
Oct 26
Why We're Not Concerned About Grown Rogue International Inc.'s (CSE:GRIN) Share Price
Jul 01Recent updates
Investors Interested In Grown Rogue International Inc.'s (CSE:GRIN) Revenues
Oct 26Why We're Not Concerned About Grown Rogue International Inc.'s (CSE:GRIN) Share Price
Jul 01Here's Why Grown Rogue International (CSE:GRIN) Has Caught The Eye Of Investors
Feb 22What Grown Rogue International Inc.'s (CSE:GRIN) P/E Is Not Telling You
Jan 24We Think Grown Rogue International (CSE:GRIN) Is Taking Some Risk With Its Debt
Oct 31Grown Rogue International's (CSE:GRIN) Earnings Offer More Than Meets The Eye
Oct 05Do Grown Rogue International's (CSE:GRIN) Earnings Warrant Your Attention?
Aug 31Grown Rogue International (CSE:GRIN) Has A Somewhat Strained Balance Sheet
Sep 17Does Grown Rogue International (CSE:GRIN) Have A Healthy Balance Sheet?
Jun 01Here's Why Grown Rogue International (CSE:GRIN) Has A Meaningful Debt Burden
Nov 10President J. Strickler Just Bought 5.4% More Shares In Grown Rogue International Inc. (CSE:GRIN)
Feb 11Shareholder Returns
| GRIN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -3.3% | -32.0% | 1.7% |
| 1Y | 128.2% | -26.5% | 23.7% |
Return vs Industry: GRIN exceeded the Canadian Pharmaceuticals industry which returned -26.5% over the past year.
Return vs Market: GRIN exceeded the Canadian Market which returned 23.7% over the past year.
Price Volatility
| GRIN volatility | |
|---|---|
| GRIN Average Weekly Movement | 9.0% |
| Pharmaceuticals Industry Average Movement | 11.7% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.9% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: GRIN has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: GRIN's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jesse Strickler | www.grownrogue.com |
Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, such as indicas, sativas, and hybrids; strain-specific prepackaged flowers; and pre-roll pack products, as well as provides consulting services. The company sells its products through direct-to-retail delivery and third-party delivery, wholesalers, and processors.
Grown Rogue International Inc. Fundamentals Summary
| GRIN fundamental statistics | |
|---|---|
| Market cap | CA$193.38m |
| Earnings (TTM) | CA$5.38m |
| Revenue (TTM) | CA$30.43m |
36.8x
P/E Ratio6.5x
P/S RatioIs GRIN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GRIN income statement (TTM) | |
|---|---|
| Revenue | US$21.83m |
| Cost of Revenue | US$7.60m |
| Gross Profit | US$14.22m |
| Other Expenses | US$10.37m |
| Earnings | US$3.86m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.017 |
| Gross Margin | 65.17% |
| Net Profit Margin | 17.67% |
| Debt/Equity Ratio | 24.9% |
How did GRIN perform over the long term?
See historical performance and comparison